|
|
TCRT-PGEN Fundamental & Technical Discussion Board
|
|
||
Anymore Insights From TUB Regarding Financing, Insider Buys, Valuation....?Some time ago Barton said it was a bet on 50 cents either going to $50 or $0. Current valuation by "Market" says we have nothing yet we have proved with Patient 1 safety and that it does shrink the tumor. Obviously, TCRT needs more patients and data to prove this process and technology. Wondered if he was another buyer at these basement prices...? AZN buying Neogene should have raised some interest from Other Pharma's and Big Bios and put some floor price in early TCRT technology. IMO, AZN is not done or for that matter other Pharma's have not started... Would love for BMY or MRK to get interested... Time will tell, but we need the positive data! |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
31590 | Re: Anymore Insights From TUB Regarding Financing, Insider Buys, Valuation....? | gjockey | 5 | 12/5/2022 8:16:46 PM |